Evidence Based Oncology™ Presents Immune-Oncology Issue Featuring Biomarkers, Combinations, CAR T-cell Coverage
Dr. Jeffrey Weber of NYU Langone Health’s Perlmutter Cancer Center and Dr. Hope Rugo of UCSF Helen Diller Comprehensive Cancer Center are among the faculty featured in Evidence-Based Oncology™, a publication of The American Journal of Managed Care®.
Biomarkers, the next wave of therapy combinations, and the challenge of payer coverage for CAR T-cell therapy are among the topics in this year’s special issue on immuno-oncology in Evidence-Based Oncology™ (EBO™), the multistakeholder publication from The American Journal of Managed Care®. The full issue can be
Since the EBO™ 2017 issue on immuno-oncology, the US Food and Drug Administration approved two chimeric antigen receptor (CAR) T-cell therapies, and this new issue features a
But in an interview on advances in care for
Dr. Hope Rugo of UCSF Helen Diller Comprehensive Cancer Center weighs in on a discussion of a biosimilar for trastuzumab, which saw a price increase in several Humana Medicare plans earlier this year. Rugo was candid in
Finally,
About The American Journal of Managed Care®:
The American Journal of Managed Care® (AJMC®) is a peer-reviewed, MEDLINE-indexed journal that keeps readers on the forefront of health policy by publishing research relevant to industry decision makers as they work to promote the efficient delivery of high-quality care. AJMC.com is the essential website for managed care professionals, distributing industry updates daily to leading stakeholders. Other titles in the AJMC® family include The American Journal of Accountable Care®, and two evidence-based series, Evidence-Based Oncology™ and Evidence-Based Diabetes Management™. These comprehensive offerings bring together stakeholder views from payers, providers, policymakers and other industry leaders in managed care. To order reprints of articles appearing in AJMC® publications, please contact Jeff Prescott at 609-716-7777, ext. 331.
Contacts:
AJMC® Media:
Theresa Burek, 609-716-7777
or
Surabhi Verma
Newsletter
Stay at the forefront of cutting-edge science with CGT—your direct line to expert insights, breakthrough data, and real-time coverage of the latest advancements in cell and gene therapy.
Related Articles
- Top News in Lymphoma Cell Therapy for World Lymphoma Awareness Day 2025
September 15th 2025
- Duchenne Action Month 2025: Looking Back at News and Expert Insights
September 14th 2025
- CGTLive®’s Weekly Rewind – September 12, 2025
September 12th 2025